Navigating Diabetes Treatments: Insights and Concerns

This chapter explores the management of a patient with a high A1C while focusing on the uptitration of oral medications beyond metformin. The discussion highlights the advantages of newer diabetes medications like SGLT2 inhibitors, including their cardiovascular and kidney benefits, as well as the hesitations clinicians face regarding costs and side effects. It also emphasizes the importance of informed decision-making and the need to monitor potential risks associated with diabetes treatments.